| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0007 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0009 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.21 | 0.001 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |